Liver Transplantation in COVID-19 Era
For ILTS members only, please join now or renew your membership.
1) Defining the risks of waiting or transplanting liver candidates in the setting of the COVID-19 pandemic.
2) Understanding the immunosuppression management strategies and anti-viral therapies for liver recipients with COVID-19.
3) Recognizing and managing other co-infections in COVID-19-infected liver candidates and recipients.
4) Understanding the efficacy of vaccination in liver transplant recipients.
Marina Berenguer (Spain)
Ashwin Rammohan (India)
Click here to view this session in the congress program.